share

Pregna-1,4-Diene-3,20-Dione, 11,21-Dihydroxy-17-(1-Oxobutoxy)-, (11β)- (9Ci) CAS NO 22958-20-9


Unit Price:

CAS No.:22958-20-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Pregna-1,4-Diene-3,20-Dione, 11,21-Dihydroxy-17-(1-Oxobutoxy)-, (11β)- (9Ci) is a high-purity steroid derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical intermediate for the synthesis of potent corticosteroid APIs, enabling the production of anti-inflammatory and immunosuppressive medications. It is primarily utilized by pharmaceutical manufacturers and R&D laboratories focused on developing next-generation therapeutic agents. Our supply ensures the stringent quality and consistency required for sensitive synthetic pathways.

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of advanced corticosteroid active pharmaceutical ingredients (APIs).
  • Anti-inflammatory Drug Research: Used in R&D for developing novel topical and systemic anti-inflammatory therapies.
  • Immunosuppressant Development: Serves as a precursor in the creation of immunosuppressive drugs for autoimmune conditions and organ transplantation.
  • Reference Standard: Employed as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.
  • Process Chemistry: Utilized in scale-up and optimization studies for commercial pharmaceutical manufacturing processes.
  • Academic & Institutional Research: Supports biochemical and pharmacological studies in university and institutional settings.

Basic Information

Item Detail
Product Name Pregna-1,4-Diene-3,20-Dione, 11,21-Dihydroxy-17-(1-Oxobutoxy)-, (11β)- (9Ci)
CAS No. 22958-20-9
Molecular Formula C₂₅H₃₄O₇
Molecular Weight 446.53 g/mol
Synonyms 11β,21-Dihydroxy-17α-butyryloxypregna-1,4-diene-3,20-dione; 17α-Butyryloxy-11β,21-dihydroxypregna-1,4-diene-3,20-dione; Butyryloxycortisone; 17-Butyrate ester of Prednisolone; Prednisolone 17-butyrate; NSC 106977; (11β)-11,21-Dihydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
EINECS Contact for details

Quality Control

Our Pregna-1,4-Diene-3,20-Dione, 11,21-Dihydroxy-17-(1-Oxobutoxy)-, (11β)- (9Ci) is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical applications. A Certificate of Analysis (COA) detailing all specifications and test results is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a low-humidity environment to prevent degradation.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥98.0%
Related Substances (HPLC) Total impurities ≤2.0%
Single Unknown Impurity ≤0.5%
Loss on Drying ≤1.0%
Residue on Ignition ≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.